Scientific Presentations

Home OCT & Notal OCT Analyzer
AAO Virtual Meeting | November 2020

Quality of Retinal Images Captured by a Self-Operated, Home-Based OCT System

Anat Loewenstein, MD
Retina Society 2020 VR | September 2020

Home OCT in the Management of AMD

Anat Loewenstein, MD

Click here to view the presentation.

ASRS 2020 Annual Meeting | July 2020

Performance of a Novel Deep Learning Algorithm for Automatic Retinal Fluid Quantification in Home OCT Images

Judy Kim, MD
ASRS 2020 Annual Meeting | July 2020

Artificial Intelligence Algorithm May Improve Performance of Retinal Specialists in Detection of Retinal Fluid on OCT in AMD: AREDS2 10-Year Study

Michael Elman, MD
42nd Annual Macula Society Meeting | February 2020

A Novel AI-Based System for Identifying, quantifying and visualizing fluid on OCT scans in retinal pathologies

Anat Loewenstein, MD

SCANLY Home OCT FDA Intended Use

SCANLY Home OCT has not been approved by FDA for use other than described in the following Intend Use: The Notal Vision Home Optical Coherence Tomography (OCT) System is an Artificial Intelligence (AI)-based Home Use device indicated for visualization of intraretinal and subretinal hypo-reflective spaces in a 10 by 10-degrees area centered on the point of fixation of eyes diagnosed with neovascular age-related macular degeneration (NV-AMD). In addition, it provides segmentation and an estimation of the volume of hypo-reflective spaces. The Notal Home OCT device is intended for imaging at home between regularly scheduled clinic assessments and not intended to be used to make treatment decisions or replace standard-of care regularly scheduled examinations and clinical testing as needed, including in-office imaging and assessments for changes in vision, by an ophthalmologist.

See also Warnings and Precautions.

ForeseeHome FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact